Clinical trial
Sphingosine-1 Phosphate -Receptor Targeting and Microglial Activation (FINGOPET)
To evaluate the usability of positron emission tomography imaging as a novel outcome measure in multiple sclerosis studies
| Category | Value |
|---|---|
| Study start date | 2014-05-08 |